| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -120 | -58 |
| Effect of exchange rate on cash and cash equivalents | 547 | 410 |
| Net (decrease) increase in cash and cash equivalents | -2,339 | -1,769 |
| Cash and cash equivalents at beginning of period | 5,374 | - |
| Cash and cash equivalents at end of period | 3,035 | - |
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA)